Benanti, G.; Secci, M.; Villatore, A.; Angiulli, S.; Calabrese, C.; Gallina, G.D.; Batani, V.; De Luca, G.; Campochiaro, C.; Pizzetti, G.;
et al. Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of Myocarditis. Microorganisms 2025, 13, 2266.
https://doi.org/10.3390/microorganisms13102266
AMA Style
Benanti G, Secci M, Villatore A, Angiulli S, Calabrese C, Gallina GD, Batani V, De Luca G, Campochiaro C, Pizzetti G,
et al. Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of Myocarditis. Microorganisms. 2025; 13(10):2266.
https://doi.org/10.3390/microorganisms13102266
Chicago/Turabian Style
Benanti, Giovanni, Marta Secci, Andrea Villatore, Sara Angiulli, Chiara Calabrese, Gabriele Domenico Gallina, Veronica Batani, Giacomo De Luca, Corrado Campochiaro, Giuseppe Pizzetti,
and et al. 2025. "Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of Myocarditis" Microorganisms 13, no. 10: 2266.
https://doi.org/10.3390/microorganisms13102266
APA Style
Benanti, G., Secci, M., Villatore, A., Angiulli, S., Calabrese, C., Gallina, G. D., Batani, V., De Luca, G., Campochiaro, C., Pizzetti, G., Peretto, G., Sala, S., Bozzolo, E. P., Moroni, L., Matucci-Cerinic, M., Ramirez, G. A., & Dagna, L.
(2025). Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of Myocarditis. Microorganisms, 13(10), 2266.
https://doi.org/10.3390/microorganisms13102266
